| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.6 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.6 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |